MCM-41 Nanoparticles for Brain Delivery: Better Choline-Esterase and Amyloid Formation Inhibition with Improved Kinetics.

The present study was aimed at delivering a low bioavailability drug, rivastigmine hydrogen tartrate (RTG), to the brain through its encapsulation in mesoporous silica nanoparticles (MSNs) and targeted to amyloid inhibition in the brain. MSNs were characterized for size, zeta potential, and drug entrapment using SEM, TEM, HR-TEM, FT-IR, and PXRD. Drug-loaded MSNs were assessed for in vitro release kinetics and ex vivo followed by animal studies.

Ruthenium Catalyzed Intramolecular C-S Coupling Reactions: Synthetic Scope and Mechanistic Insight.

A ruthenium catalyzed intramolecular C-S coupling reaction of N-arylthioureas for the synthesis of 2-aminobenzothiazoles has been developed. Kinetic, isotope labeling, and computational studies reveal the involvement of an electrophilic ruthenation pathway instead of a direct C-H activation. Stereoelectronic effect of meta-substituents on the N-arylthiourea dictates the final regioselective outcome of the reaction.

Multicomponent assembly of anionic and neutral decanuclear copper(II) phosphonate cages.

A multicomponent synthetic strategy involving copper(II) ions, tert-butylphosphonic acid (t-BuPO(3)H(2)) and 3-substituted pyrazole ligands has been adopted for the synthesis of soluble molecular copper(II) phosphonates. The use of six different 3-substituted pyrazoles, 3-R-PzH [R = H, Me, CF(3), Ph, 2-pyridyl (2-Py), and 2-methoxyphenyl (2-MeO-C(6)H(4))] as ancillary ligands afforded nine different decanuclear cages, [Cu(5)(μ(3)-OH)(2)(O(3)P-t-Bu)(3)(3-R-Pz)(2)(X)(2)](2)·(Y) where R = H, X = t-BuPO(3)H, and Y = (Et(3)NH(+))(4)(solvent) (1); R = Me, X = 3-MePzH, and Y = solvent (2); R = Me, X = t-BuPO(3)H, and Y = (Et(3)NH(+))(4)(solvent) (3); R = CF(3), X = t-BuPO(3)H, and Y = (Et(3)NH(+))(4)(solvent) (4); R = Ph, X = 3-PhPzH, and Y = solvent (5); R = 2-Py, X = 0.5 MeOH, and Y = solvent (6); R = 2-Py, X = none, and Y = solvent (7); R = 2-Py, X = H(2)O, and Y = (Et(3)NH(+)·PF(6)(-))(2)(solvent) (8); R = 2-MeO-C(6)H(4), X = MeOH or 0.

Octa- and hexametallic iron(III)-potassium phosphonate cages.

Two new iron(III)-potassium phosphonate cage complexes with {K(2)Fe(6)} and {K(2)Fe(4)} cores are reported. Magnetic studies reveal antiferromagnetic interactions between the Fe(III) centres occur in these cages.

Assembly of a dinuclear silver complex containing an Ag2S2 motif from a phosphorus-supported trishydrazone ligand. P=S→Ag(I) coordination.

The reaction of the phosphorus trihydrazide, (S)P[N(Me)-NH(2)](3) (1) with quinoline-2-carboxaldehyde (C(9)H(6)N-2-CHO) in a 1:3 ratio afforded a trishydrazone, (S)P[N(Me)-N=CH-2-C(9)H(6)N](3) (2). Crystals of 2 were grown in three different solvent media affording an unsolvated (2, monoclinic, P2(1)/n) and two solvated (2·3H(2)O, trigonal, R3 and 2·2CH(3)OH, triclinic, P ̅1) crystal forms. Each of these, while possessing an essentially similar molecular structure, adopt different crystal packing giving rise to supramolecular structures mediated by a variety of weak interactions: O-H-N, O-H-O, C-H-N, C-H-O, C-H-S, C-H-π, π-π, N-π and S-π.

3d-4f clusters with large spin ground states and SMM behaviour.

Three new Cu-Ln cage complexes bridged by phosphonates and acetates are reported; one--a Cu(24)Dy(8) cage--is a new single molecule magnet (SMM).

Nanodimensional organostannoxane molecular assemblies.

Organooxotin cages, clusters, and coordination polymers containing [Sn 2(mu-O)], [Sn 2(mu-OH)], [Sn 2(mu-O) 2], [Sn 2(mu-OH) 2], and [Sn 3(mu 3-O)(mu-OR) 3] building blocks have been assembled by the reactions of organotin precursors with phosphonic, phosphinic, carboxylic, or sulfonic acids. Various synthetic methodologies including Sn-C bond cleavage reactions and solventless procedures have been utilized to generate several nanodimensional organostannoxane assemblies. The synthesis, structure, and structural interrelationship of these diverse organostannoxane compounds are discussed.

A new structural form for a decanuclear copper(II) assembly.

The synthesis and structure of a novel decanuclear copper(II) cage is reported. The assembly of the cage is facilitated by the cumulative coordinative interaction of tert-butyl phosphonate, 2-pyridylpyrazole and hydroxide ligands with copper(II) ions. Magnetic studies of this decanuclear copper(II) cage indicate complex antiferromagnetic behaviour.

Organostannoxane-supported multiferrocenyl assemblies: synthesis, novel supramolecular structures, and electrochemistry.

Organostannoxane-based multiredox assemblies containing ferrocenyl peripheries have been readily synthesized by a simple one-pot synthesis, either by a solution method or by room-temperature solid-state synthesis, in nearly quantitative yields. The number of ferrocenyl units in the multiredox assembly is readily varied by stoichiometric control as well as by the choice of the organotin precursors. Thus, the reaction of the diorganotin oxides, R2SnO (R = Ph, nBu and tBu) with ferrocene carboxylic acid affords tetra-, di-, and mononuclear derivatives [{Ph2Sn[OC(O)Fc]2}2] (1), [{[nBu2SnOC(O)Fc]2O}2] (2), [nBu2Sn{OC(O)Fc}2] (3), [{tBu2Sn(OH)OC(O)Fc}2] (4), and [tBu2Sn{OC(O)Fc}2] (5) (Fc = eta(5)C5H4-Fe-eta(5)C5H5).

First example of a Sn-C bond cleaved product in the reaction of Ph3SnOSnPh3 with carboxylic acids. 3D-supramolecular network formation in the X-ray crystal structure of [Ph2Sn(OH)OC(O)(Rf)]2, Rf = 2,4,6-(CF3)3C6H2.

A 1:2 reaction of Ph3SnOSnPh3 1 with RfCOOH 2 leads to the formation of [Ph2Sn(OH)OC(O)(Rf)]2 3, by means of a facile Sn-C bond cleavage process.